微小RNA调控肿瘤相关巨噬细胞极化在重塑乳腺癌免疫微环境中的作用

doi:10.3760/cma.j.cn371439-20200401-00050

国际肿瘤学杂志 ›› 2020, Vol. 47 ›› Issue (7): 428-430.doi: 10.3760/cma.j.cn371439-20200401-00050

微小RNA调控肿瘤相关巨噬细胞极化在重塑乳腺癌免疫微环境中的作用

周佳敏, 叶莉莎, 王国华()

南通大学特种医学研究院 226001

收稿日期:2020-04-01 修回日期:2020-04-10 出版日期:2020-07-08 发布日期:2020-08-18
通讯作者: 王国华 E-mail:wgh@ntu.edu.cn
基金资助:
国家自然科学基金(81471257);江苏省重点研发计划(BE2018778);江苏省第五期“333工程”科研项目(BAR2019207);南通市科技计划(MS12018029)

Roles of microRNA in the regulation of tumor-associated macrophage polarization during the remodeling of breast cancer immune microenvironment

Zhou Jiamin, Ye Lisha, Wang Guohua()

Institute of Special Environmental Medicine, Nantong University, Nantong 226001, China

Received:2020-04-01 Revised:2020-04-10 Online:2020-07-08 Published:2020-08-18
Contact: Wang Guohua E-mail:wgh@ntu.edu.cn
Supported by:
National Natural Science Foundation of China(81471257);Primary Research and Development Plan of Jiangsu Province(BE2018778);The Fifth "333 Project" of Jiangsu Province(BAR2019207);Nantong Science and Technology Plan(MS12018029)

摘要/Abstract

摘要：

肿瘤相关巨噬细胞(TAM)作为肿瘤微环境中的主要免疫细胞已成为乳腺癌进展的重要参与者。微小RNA(miRNA)可调控转录后基因表达而改变TAM功能,影响其极化分型及转化,最终影响乳腺癌的发生、发展。了解miRNA在TAM极化中的作用机制,可为乳腺癌的治疗提供新的诊断思路与临床治疗策略。

关键词: 乳腺肿瘤, 肿瘤微环境, 巨噬细胞, 微RNAs

Abstract:

Tumor associated macrophage (TAM), as the main type of immune cells in tumor microenvironment, becomes an active participant in the development of breast cancer. MicroRNA (miRNA) can regulate post-transcriptional gene expression, modulation of macrophage function by affecting its polarization typing and transformation, and ultimately contribute to the occurrence and development of breast cancer. It could provide a new diagnosis and clinical treatment strategy for the treatment of breast cancer by summarizing the mechanisms of miRNA in the polarization of TAM.

Key words: Breast neoplasms, Tumor microenvironment, Macrophages, MicroRNAs

周佳敏, 叶莉莎, 王国华. 微小RNA调控肿瘤相关巨噬细胞极化在重塑乳腺癌免疫微环境中的作用[J]. 国际肿瘤学杂志, 2020, 47(7): 428-430.

Zhou Jiamin, Ye Lisha, Wang Guohua. Roles of microRNA in the regulation of tumor-associated macrophage polarization during the remodeling of breast cancer immune microenvironment[J]. Journal of International Oncology, 2020, 47(7): 428-430.

参考文献 20

[1]	郑新宇, 王秋丽. 2015年欧洲肿瘤内科学会《原发性乳腺癌诊断、治疗及随访指南》解读[J]. 中国实用外科杂志, 2016,36(7):763-770. DOI: 10.7504/CJPS.ISSN1005-2208.2016.07.14.
[2]	Ward EM, Desantis CE, Lin CC, et al. Cancer statistics: breast cancer in situ[J]. CA Cancer J Clin, 2015,65(6):481-495. DOI: 10.3322/caac.21321. doi: 10.3322/caac.21321 pmid: 26431342
[3]	Li K, Wei L, Huang Y, et al. Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion[J]. Int J Oncol, 2016,48(6):2479-2487. DOI: 10.3892/ijo.2016.3483. doi: 10.3892/ijo.2016.3483 pmid: 27082857
[4]	Kasahara VA, do Carmo Nicoletti M. Graph-based clustering of miRNA sequences[J]. Microrna, 2017,6(3):166-186. DOI: 10.2174/2211536606666170724154752. doi: 10.2174/2211536606666170724154752 pmid: 28738776
[5]	Roy S. miRNA in macrophage development and function[J]. Antioxid Redox Signal, 2016,25(15):795-804. DOI: 10.1089/ars.2016.6728. doi: 10.1089/ars.2016.6728 pmid: 27353423
[6]	Ngambenjawong C, Gustafson HH, Pun SH. Progress in tumor-associated macrophage (TAM)-targeted therapeutics[J]. Adv Drug Deliv Rev, 2017,114:206-221. DOI: 10.1016/j.addr.2017.04.010. pmid: 28449873
[7]	李悦, 高磊, 李红昌, 等. M2型巨噬细胞标志物CD206与肿瘤[J]. 国际肿瘤学杂志, 2019,46(3):174-177. DOI: 10.3760/cma.j.issn.1673-422X.2019.03.009.
[8]	Falleni M, Savi F, Tosi D, et al. M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma[J]. Melanoma Res, 2017,27(3):200-210. DOI: 10.1097/CMR.0000000000000352. pmid: 28272106
[9]	Bednarczyk RB, Tuli NY, Hanly EK, et al. Macrophage inflam-matory factors promote epithelial-mesenchymal transition in breast cancer[J]. Oncotarget, 2018,9(36):24272-24282. DOI: 10.18632/oncotarget.24917. doi: 10.18632/oncotarget.24917 pmid: 29849939
[10]	Mu X, Shi W, Xu Y, et al. Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer[J]. Cell Cycle, 2018,17(4):428-438. DOI: 10.1080/15384101.2018.1444305. pmid: 29468929
[11]	Grossman JG, Nywening TM, Belt BA, et al. Recruitment of CCR2⁺ tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer [J]. Oncoimmunology, 2018,7(9):e1470729. DOI: 10.1080/2162402X.2018.1470729. pmid: 30228938
[12]	Ghoochani A, Schwarz MA, Yakubov E, et al. MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis[J]. Oncogene, 2016,35(48):6246-6261. DOI: 10.1038/onc.2016.160. pmid: 27157615
[13]	Cui M, Yao X, Li Y, et al. Interactive functions of microRNAs in the miR-23a-27a-24-2 cluster and the potential for targeted therapy in cancer[J]. J Cell Physiol, 2020,235(1):6-16. DOI: 10.1002/jcp.28958. doi: 10.1002/jcp.28958 pmid: 31192453
[14]	Ma S, Liu M, Xu Z, et al. A double feedback loop mediated by microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression[J]. Oncotarget, 2016,7(12):13502-13519. DOI: 10.18632/oncotarget.6284. doi: 10.18632/oncotarget.6284 pmid: 26540574
[15]	Zhong Y, Yi C. MicroRNA-720 suppresses M2 macrophage polari-zation by targeting GATA3[J]. Biosci Rep, 2016,36(4):e00363. DOI: 10.1042/BSR20160105. pmid: 27354564
[16]	Weng YS, Tseng HY, Chen YA, et al. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer[J]. Mol Cancer, 2019,18(1):42. DOI: 10.1186/s12943-019-0988-0. doi: 10.1186/s12943-019-0988-0 pmid: 30885232
[17]	Jia X, Li X, Shen Y, et al. MiR-16 regulates mouse peritoneal macrophage polarization and affects T-cell activation[J]. J Cell Mol Med, 2016,20(10):1898-1907. DOI: 10.1111/jcmm.12882. doi: 10.1111/jcmm.12882 pmid: 27241533
[18]	Wang W, Liu Y, Guo J, et al. miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a/IL-1ra pathway in mouse breast cancer[J]. Oncogenesis, 2018,7(12):97. DOI: 10.1038/s41389-018-0106-y. doi: 10.1038/s41389-018-0106-y pmid: 30563983
[19]	Li Y, Zhao L, Shi B, et al. Functions of miR-146a and miR-222 in tumor-associated macrophages in breast cancer[J]. Sci Rep, 2015,5:18648. DOI: 10.1038/srep18648. pmid: 26689540
[20]	Frank AC, Ebersberger S, Fink AF, et al. Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype[J]. Nat Commun, 2019,10(1):1135. DOI: 10.1038/s41467-019-08989-2. doi: 10.1038/s41467-019-08989-2 pmid: 30850595

微小RNA调控肿瘤相关巨噬细胞极化在重塑乳腺癌免疫微环境中的作用

Roles of microRNA in the regulation of tumor-associated macrophage polarization during the remodeling of breast cancer immune microenvironment

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 20

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[2]	傅旖, 马辰莺, 张露, 周菊英. 生境分析在恶性肿瘤影像组学中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(5): 292-297.
[3]	萨蔷, 徐航程, 王佳玉. 乳腺癌免疫治疗研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 227-234.
[4]	杨智, 陆以乔, 顾花艳, 丁佳玲, 郭贵龙. 肿瘤微环境介导乳腺癌靶向治疗耐药的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 235-238.
[5]	龚艳, 陈洪雷. 微RNA调控卵巢癌顺铂耐药的机制研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 186-190.
[6]	陈波光, 王苏贵, 张永杰. 血清胆碱酯酶与炎症标志物在ⅠA~ⅢA期乳腺癌预后中的作用[J]. 国际肿瘤学杂志, 2024, 51(2): 73-82.
[7]	刘筱迪, 苏剑飞, 张静娴, 卫雪芹, 贾英杰. 髓源性抑制细胞在肿瘤血管生成中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(1): 50-54.
[8]	顾花艳, 朱腾, 郭贵龙. 乳房微生物群与乳腺癌：现状与未来[J]. 国际肿瘤学杂志, 2024, 51(1): 55-58.
[9]	王景, 许文婷. 中性粒细胞与淋巴细胞比值、癌胚抗原联合凝血指标对直径≤1.0 cm的良恶性乳腺结节鉴别诊断价值研究[J]. 国际肿瘤学杂志, 2023, 50(9): 520-526.
[10]	冯诚天, 黄芙蓉, 曹世玉, 王健宇, 南丁阿比雅思, 姜永冬, 朱娟英. HER2阳性乳腺癌患者HER2表达水平与影像学特征的关系[J]. 国际肿瘤学杂志, 2023, 50(9): 527-531.
[11]	冯东旭, 吴炜, 高平发, 王军, 施丽娟, 陈大伟, 李文兵, 张美峰. miR-451通过调控Rho/ROCK1信号通路对乳腺癌细胞糖酵解及凋亡的影响[J]. 国际肿瘤学杂志, 2023, 50(8): 449-456.
[12]	贺嘉慧, 胡钦勇. 放疗联合特瑞普利单抗和GM-CSF治疗鼻腔鼻窦腺样囊性癌1例并文献复习[J]. 国际肿瘤学杂志, 2023, 50(7): 442-444.
[13]	王文德, 曾德. 乳腺癌内分泌治疗耐药的机制研究进展[J]. 国际肿瘤学杂志, 2023, 50(6): 352-356.
[14]	李青珊, 谢鑫, 张楠, 刘帅. 放疗联合系统治疗在乳腺癌中的应用进展[J]. 国际肿瘤学杂志, 2023, 50(6): 362-367.
[15]	张丽, 向卓, 王强, 毕经旺. CAR-T免疫治疗相关的细胞因子释放综合征研究进展[J]. 国际肿瘤学杂志, 2023, 50(6): 377-381.